• About
• Latest Posts
• Latest Blog Posts
• Boards Posted On
• Boards Moderating

SeekingAlfa

Send Private Message

Follow Member

Block Messages

Ignore This User

Displaying 1-50 of 72 result(s).

Board Name	Posts By SeekingAlfa	Post Created
GNBTQ Generex Biotechnology Corp.	Krilac Lawrence Salvo? Stephen Berk	09/15/2021 8:54:01 PM
GNBTQ Generex Biotechnology Corp.	Has the company gone into a coma ag	08/22/2021 9:54:03 AM
GNBTQ Generex Biotechnology Corp.	If the stock drops to a penny, Joe (2)	08/19/2021 5:49:05 PM
GNBTQ Generex Biotechnology Corp.	Has anyone heard anything about the	08/06/2021 8:25:59 PM
GNBTQ Generex Biotechnology Corp.	A lot of CYDY shareholders are Gene (3)	07/20/2021 8:35:45 PM
GNBTQ Generex Biotechnology Corp.	Thanks for posting docj. It shows h (5)	07/04/2021 12:13:27 PM
GNBTQ Generex Biotechnology Corp.	MediWound (MDWD) is up 14%. Is this (3)	06/10/2021 5:59:33 PM
GNBTQ Generex Biotechnology Corp.	Does anyone know the status of the	06/07/2021 7:42:03 PM
GNBTQ Generex Biotechnology Corp.	Biogen up 38% on a really junky equ	06/07/2021 7:41:20 PM
GNBTQ Generex Biotechnology Corp.	PBS reports complete lockdown in Ma	06/02/2021 12:04:55 AM
GNBTQ Generex Biotechnology Corp.	Remote Patient Monitoring (RPM) dur (2)	05/11/2021 11:03:15 AM
GNBTQ Generex Biotechnology Corp.	Hey Zolis_onkel, Maybe there is not (5)	05/06/2021 3:02:40 PM
GNBTQ Generex Biotechnology Corp.	Of course if people think like roth	03/16/2021 1:58:45 PM
GNBTQ Generex Biotechnology Corp.	CYDY shareholders. The water's fine (2)	03/09/2021 12:54:49 PM
GNBTQ Generex Biotechnology Corp.	The British variant. The South Afri (2)	03/08/2021 9:27:28 AM
GNBTQ Generex Biotechnology Corp.	Sadly, March could go by and we won (2)	03/06/2021 2:49:42 PM
GNBTQ Generex Biotechnology Corp.	Withdrawn. (1)	01/11/2021 3:26:29 PM
GNBTQ Generex Biotechnology Corp.	Either GNBT has to go up, or NGIO v (7)	01/11/2021 2:53:51 PM
GNBTQ Generex Biotechnology Corp.	Does anyone have a good idea about	01/09/2021 6:34:04 PM
GNBTQ Generex Biotechnology Corp.	docj, hoping for your speedy recove (2)	12/01/2020 12:04:01 AM
GNBTQ Generex Biotechnology Corp.	The news appears is favorable. Chin (2)	11/23/2020 3:19:24 PM
GNBTQ Generex Biotechnology Corp.	The news is good, great. Selling by (5)	11/18/2020 12:06:40 PM
CYDY CytoDyn Inc	So what are we expecting from the S	10/13/2020 11:20:28 PM
GNBTQ Generex Biotechnology Corp.	Somebody Tell Trump's Doctors About (2)	10/04/2020 10:45:44 AM
GNBTQ Generex Biotechnology Corp.	Horse before the cart. This time Jo (3)	10/04/2020 10:44:12 AM
CYDY CytoDyn Inc	Somebody Tell Trump's Doctors about (1)	10/04/2020 9:53:16 AM
CYDY CytoDyn Inc	Snatching defeat from the jaws of v (5)	10/01/2020 10:06:38 AM
CYDY CytoDyn Inc	They keep doing these conference ca (2)	09/30/2020 1:54:37 PM
CYDY CytoDyn Inc	We really need the severe to critic (1)	09/13/2020 10:55:29 AM
GNBTQ Generex Biotechnology Corp.	We were better off before the Confe	08/28/2020 11:48:30 AM
CYDY CytoDyn Inc	If we hit both our primary and seco (1)	08/26/2020 1:47:07 PM
CYDY CytoDyn Inc	Primary Endpoint. I thought Cytodyn (2)	08/26/2020 1:19:02 PM
CYDY CytoDyn Inc	I don't know what it will take to i	08/11/2020 10:19:06 AM
CYDY CytoDyn Inc	Yes, Wall Street Journal article re	08/05/2020 4:20:36 PM
CYDY CytoDyn Inc	Short attack? Results were good. I' (1)	07/21/2020 9:53:08 AM
GNBTQ Generex Biotechnology Corp.	The conference call did not move th (4)	07/15/2020 10:01:20 PM
CYDY CytoDyn Inc	Anticipation climb from here. Nothi (3)	07/13/2020 6:39:59 PM
CYDY CytoDyn Inc	All we know is that Nader Pourhassa (1)	07/13/2020 2:33:07 PM
CYDY CytoDyn Inc	Listen to the video yourself. When (1)	07/01/2020 5:41:32 PM
GNBTQ Generex Biotechnology Corp.	Good to see GNBT break thru $.65. H (5)	06/30/2020 7:15:15 PM
GNBTQ Generex Biotechnology Corp.	I expected that Joe would draw down (1)	06/30/2020 9:54:22 AM
GNBTQ Generex Biotechnology Corp.	My two cents, but I think money com	06/29/2020 8:54:59 PM
GNBTQ Generex Biotechnology Corp.	Yeah, I too followed docj's breadcr (1)	06/29/2020 6:33:32 PM
GNBTQ Generex Biotechnology Corp.	I would like to see the Board of Di (1)	06/28/2020 10:30:05 PM
CYDY CytoDyn Inc	Okay, looks like we will be 5 conse	06/26/2020 1:45:31 PM
GNBTQ Generex Biotechnology Corp.	I can remember the original reason	06/26/2020 7:59:26 AM
CYDY CytoDyn Inc	Rbarb100 made an excellent effort t (6)	06/24/2020 4:44:41 PM
CYDY CytoDyn Inc	Human Challenge Trials If leronlima (4)	06/15/2020 8:04:04 PM
GNBTQ Generex Biotechnology Corp.	I wonder why there was no 8K for Ba (2)	06/09/2020 11:13:48 PM
CYDY CytoDyn Inc	I think I will skip the live presen (2)	06/01/2020 12:08:13 PM

• Next >

62414316221289621968162086166191110617525561575636154377615437561496786131602612831560833096078370607655160754146015125601506160135605976860597136459665655928702591782959178285917809591472559136275892109587727958746565874590585638058509215833456582819858253355824994581338358120475811027581053458104745809232580798858072515805619579651757916275783504

Recent Articles

• AT&T Maintains Network Security Amid Chinese Cyber Threats
• Investors Urged to Act on PACS Group Inc. Securities Fraud Claims
• Quanterix Corporation Faces Investigation Amid Investor Concerns
• Investors Urged to Act in Caribou Biosciences Class Action
• CryptoQuant CEO Explores the Challenges of Bitcoin Adoption
• Discover the Allure of Luxury Real Estate in Park City
• Exploring Luxury Real Estate Investments and Ski Properties
• Rosen Law Firm Investigates IMX Token for Potential Investor Recovery
• Tech Leaders Embrace Trump: Change in Corporate Dynamics
• Investigation Launched on Fairness of ATSG Acquisition Deal
• Investor Rights Firm Investigates Zuora, Inc. Sale to Silver Lake
• Azerbaijan Airlines Incident Highlights Safety Concerns in Aviation
• Investigating Avid Bioservices Sale: Fairness for Shareholders?
• Scaramucci Advises Musk: Embrace Business, Avoid Politics
• Investigating the Fairness of ROIC Sale to Blackstone
• Investigation into Brightcove Inc. Sale and Shareholder Rights
• Investigation into Summit Materials Sale Raises Shareholder Concerns
• Understanding the Class Action Suit Against Wolfspeed, Inc.
• Investigation Launched into EnLink Midstream Sale to ONEOK
• Concerns on Public Media Funding Amid Political Turmoil
• Brookdale Senior Living Stock Hits Low as Challenges Mount
• Tunisian Central Bank Maintains Interest Rate Amid Inflation
• Investigation Launched: Is Adams Resources & Energy Fairly Sold?
• Investigation into Altair Engineering's Sale to Siemens Unfolds
• Investigation Launched on Fairness of Universal Stainless Acquisition
• Investigation Launched on Liberty Broadband's Sale to Charter
• Investor Inquiry: FLIC Sale to ConnectOne Under Scrutiny
• Investigation Launched on Aerovate Therapeutics Merger Deal
• Nationwide Support for Life Insurance Claims by Turchin Law
• Investigation into ConnectOne Bancorp Merger Fairness for Shareholders
• Sweet James Spreads Holiday Cheer with Generous Toy Donations
• Call to Action for Press Freedom and Cecilia Sala's Release
• ProShares Expands Bitcoin ETF Lineup with Innovative Offerings
• Experience the Joyful Holiday Celebrations at Watercrest
• Rise of Older Homebuyers: A Shift in the Housing Market
• Legal Action for Customers Bancorp Investors: Important Details
• Forecasting Bitcoin's Rise: Insights for 2025 and Beyond
• Surprising Christmas Gifts from Mary Trump's Uncle Revealed
• Investor Alert: Light & Wonder, Inc. Seeks Class Action Participants
• Exploring Top Stocks: Quantum Computing, Tesla, and Dogecoin Growth
• Immunovia Sets Exercise Price for TO2 Warrants and Funding Details
• Important Deadline Approaches for $JENNER Cryptocurrency Buyers
• Investors of Applied Therapeutics, Inc. Urged to Act Now
• Immunovia Strengthens Warrant Program with Secured Funding
• Immunovia Updates on Warrant Series TO 2: Pricing and Commitments
• CURE Auto Insurance Celebrates 2024 Recognition for Excellence
• From Bus to Home: Young YouTuber's $57K Transformation Journey
• JETOUR T2 i-DM Launch: A New Era for Hybrid SUVs
• Investor Alert: Join the Cassava Sciences Class Action Now
• Opportunity for Kyverna Investors to Lead Class Action Suit